Patients
POEMS syndrome, amyloidosis, infections
INFECTIONS, PLASMA CELL LEUKEMIA, AMYLOIDOSIS, POEMS SYNDROME, PERIPHERAL NEUROPATHY
Treatment naïve, NDMM, aged between 18–75 years, and who had an Eastern Cooperative Group Performance Status (ECOG PS) 2 or below were eligible. Previous local radiotherapy should have been completed at least two weeks before the study inclusion. Patients were excluded if they had ≥grade 2 peripheral neuropathy, absolute neutrophil count (ANC) < 1000, platelet count <50,000, total bilirubin and transaminases elevated three or more times the upper limit of normal, creatinine clearance <15 ml/min, or other significant and active comorbidities or infections. Patients with plasma cell leukemia, amyloidosis, and POEMS syndrome were excluded.